Radiology Partners' Cognita Chest X-ray AI tool earns FDA Breakthrough Device status for multiple clinical uses.
Key Details
- 1Radiology Partners' Cognita business received FDA Breakthrough Device designation for its Chest X-ray AI tool.
- 2The tool uses a generative vision-language model to assist radiologists in X-ray interpretation.
- 3This is among the first vision-language AI solutions in radiology to receive this designation.
- 4Breakthrough status expedites regulatory review for devices addressing critical needs.
- 5Cognita CXR integrates into radiology workflows to generate comprehensive preliminary reports for physician review.
Why It Matters
FDA Breakthrough Device designation is a major step for AI-driven radiology tools, signaling both clinical promise and regulatory progress. This can accelerate the path toward broader clinical deployment of advanced AI models in everyday radiology practice.
Source
Radiology Business
Related News
•Radiology Business
Harrison.ai Restructures and Launches U.S. AI-Enabled Teleradiology Venture
Harrison.ai lays off staff amid major restructuring and launches Frontier Radiology, an AI-powered U.S. teleradiology business.
•Radiology Business
Healthcare Leader Warns AI Will Dominate Diagnostic Radiology
A leading oncologist urges future radiologists to specialize in interventional procedures due to AI advances in image interpretation.
•Radiology Business
AI Model Surpasses Radiologists in Detecting Subtle Hip Fractures
A new AI model outperformed radiologists in identifying difficult-to-detect femoral neck fractures on radiographs.